Literature DB >> 1334847

Tumor necrosis factor alpha stimulates sphingomyelinase through the 55 kDa receptor in HL-60 cells.

F Yanaga1, S P Watson.   

Abstract

Tumor necrosis factor alpha (TNF alpha) stimulated rapid (seconds) hydrolysis of sphingomyelin in HL-60 cells, formation of phosphocholine (PCho) and a decrease in choline. The response to TNF alpha was concentration dependent with a maximal effect at 3-10 nM. The monoclonal antibody (mAb), htr-9, which behaves as an agonist at the 55 kDa subtype of the TNF receptor, also stimulated sphingomyelin hydrolysis in intact cells. In contrast, the mAb, utr-1, which behaves as an antagonist at the 75 kDa receptor subtype, had no effect on sphingomyelin hydrolysis either on its own or in the presence of TNF alpha. In addition, htr-9 or TNF alpha stimulated hydrolysis of sphingomyelin in a membrane fraction of HL-60 cells. These results are consistent with a role of sphingomyelin hydrolysis as an early event in the signalling mechanism of TNF alpha, and suggest that this pathway is activated through the 55 kDa subtype of the TNF receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334847     DOI: 10.1016/0014-5793(92)81493-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism.

Authors:  M J Courtney; K E Akerman; E T Coffey
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

2.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

Authors:  K A Krown; M T Page; C Nguyen; D Zechner; V Gutierrez; K L Comstock; C C Glembotski; P J Quintana; R A Sabbadini
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

3.  Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?

Authors:  S Tomiuk; K Hofmann; M Nix; M Zumbansen; W Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest.

Authors:  G S Dbaibo; M Y Pushkareva; S Jayadev; J K Schwarz; J M Horowitz; L M Obeid; Y A Hannun
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  A Novel Combination of Fruits and Vegetables Prevents Diet-Induced Hepatic Steatosis and Metabolic Dysfunction in Mice.

Authors:  Weimin Guo; Dayong Wu; Maria C Dao; Lijun Li; Erin D Lewis; Edwin F Ortega; Heesun Eom; Michael Thomas; Mariana Nikolova-Karakashian; Mohsen Meydani; Simin N Meydani
Journal:  J Nutr       Date:  2020-11-19       Impact factor: 4.798

6.  Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway.

Authors:  W D Jarvis; R N Kolesnick; F A Fornari; R S Traylor; D A Gewirtz; S Grant
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

7.  Ceramide does not mediate the effect of tumour necrosis factor alpha on superoxide generation in human neutrophils.

Authors:  F Yanaga; S P Watson
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

8.  Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.

Authors:  N Andrieu; R Salvayre; T Levade
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

9.  Programmed cell death in neurotumour cells involves the generation of ceramide.

Authors:  D A Wiesner; G Dawson
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

10.  Tumor necrosis factor (TNF)-alpha activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase.

Authors:  C Belka; K Wiegmann; D Adam; R Holland; M Neuloh; F Herrmann; M Krönke; M A Brach
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.